Baxter Bioscience Executive Elected to California Healthcare Institute Board.Business Editors and Health/Medical Writers BIOWIRE2K LA JOLLA La Jolla (lə hoi`yə), on the Pacific Ocean, S Calif., an uninc. district within the confines of San Diego; founded 1869. The beautiful ocean beaches, in particular La Jolla shores and Black's Beach, and sea-washed caves attract visitors and , Calif.--(BUSINESS WIRE)--Oct. 30, 2002 Lawrence P. Guiheen, president of BioPharmaceuticals, Baxter BioScience, was elected to the board of directors of California Healthcare Institute (CHI). CHI is a non-profit public policy research organization representing leading California academic institutions, biotechnology, medical device, diagnostics and pharmaceutical firms. "Larry brings a wealth of experience and a global perspective to the CHI board," David Gollaher, Ph.D., president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , CHI said. "With Baxter's growing presence in California, and the importance of the Ventura region as a biotech cluster, he is an excellent addition to our coalition." Guiheen has global responsibility for sales and marketing of biopharmaceuticals for Baxter BioScience, a business of Baxter International Baxter International Inc. (NYSE: BAX), is a global healthcare company with 48,000 employees and 2006 sales of US$10.4 billion. Its headquarters is in Deerfield, Illinois. . Prior to his current position, Guiheen was president of Baxter BioScience North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. , having served in that capacity since 1998. Guiheen joined Baxter Healthcare Corp. in 1978 as a field sales representative and quickly progressed through a variety of positions of increasing responsibility in sales, marketing, and operations in several business units of Baxter. Prior to joining Baxter, Guiheen worked for Johnson and Johnson in field sales. CHI represents more than 200 leading medical device, biotechnology, diagnostics, and pharmaceutical companies, and public and private academic biomedical research Biomedical research (or experimental medicine), in general simply known as medical research, is the basic research or applied research conducted to aid the body of knowledge in the field of medicine. organizations. CHI's mission is to advance responsible public policies that foster medical innovation and promote scientific discovery. CHI's Web site is http://www.chi.org. Baxter BioScience develops and produces therapeutic proteins from plasma and through recombinant methods to treat hemophilia hemophilia (hē'məfĭl`ēə,–fēl`yə), genetic disease in which the clotting ability of the blood is impaired and excessive bleeding results. , immune deficiencies immune deficiency n. See immunodeficiency. and other blood-related disorders. The product portfolio includes coagulation factors, immune globulins, albumin, vaccines, and biosurgery products. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion